Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?

Leukemia

Volumn 27, Issue 9, 2013, Pages 1930-1932

  Vorechovsky, I ^a   Jones, A V ^a   Cross, N C P ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; JANUS KINASE 2; PHENYLALANINE; PROTEIN SH2; RNA; SERINE ARGININE RICH PROTEIN;

BASE PAIRING; DNA SUPERCOILING; DNA TRANSCRIPTION; EXON; GENE MUTATION; GENE SEQUENCE; HUMAN; INTRON; LETTER; MUTAGENESIS; MYELOPROLIFERATIVE NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASE SEQUENCE; EXONS; HUMANS; JANUS KINASE 2; MUTATION; MYELOPROLIFERATIVE DISORDERS; NUCLEIC ACID CONFORMATION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84883740009     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.85     Document Type: Letter

References (15)

1. Scott LM. The JAK2 exon 12 mutations: a comprehensive review. Am J Hematol 2011; 86: 668-676.
2. Kjaer L, Westman M, Hasselbalch Riley C, Hogdall E, Weis Bjerrum O, Hasselbalch H. A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden. PLoS One 2012; 7: e33100.
3. Cazzola M. Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis. Haematologica 2007; 92: 1585-1589. (Pubitemid 350248235)
4. Kim N, Jinks-Robertson S. Transcription as a source of genome instability. Nat Rev Genet 2012; 13: 204-214.
5. Wright BE, Reimers JM, Schmidt KH, Reschke DK. Hypermutable bases in the p53 cancer gene are at vulnerable positions in DNA secondary structures. Cancer Res 2002; 62: 5641-5644. (Pubitemid 35204714)
6. Hoede C, Denamur E, Tenaillon O. Selection acts on DNA secondary structures to decrease transcriptional mutagenesis. PLoS Genet 2006; 2: e176.
7. Wright BE, Reschke DK, Schmidt KH, Reimers JM, Knight W. Predicting mutation frequencies in stem-loop structures of derepressed genes: implications for evolution. Mol Microbiol 2003; 48: 429-441. (Pubitemid 36819079)
8. Lippert MJ, Freedman JA, Barber MA, Jinks-Robertson S. Identification of a distinctive mutation spectrum associated with high levels of transcription in yeast. Mol Cell Biol 2004; 24: 4801-4809. (Pubitemid 38668046)
9. Warf MB, Berglund JA. Role of RNA structure in regulating pre-mRNA splicing. Trends Biochem Sci 2010; 35: 169-178.
10. Li X, Manley JL. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 2005; 122: 365-378. (Pubitemid 41127139)
11. Xiao R, Sun Y, Ding JH, Lin S, Rose DW, Rosenfeld MG et al. Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol Cell Biol 2007; 27: 5393-5402. (Pubitemid 47124393)
12. Fnu S, Williamson EA, De Haro LP, Brenneman M, Wray J, Shaheen M et al. Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining. Proc Natl Acad Sci USA 2010; 108: 540-545.
13. Wu P, Nakano S, Sugimoto N. Temperature dependence of thermodynamic properties for DNA/DNA and RNA/DNA duplex formation. Eur J Biochem 2002; 269: 2821-2830. (Pubitemid 34754009)
14. Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Lancet 2008; 372: 1484-1492.
15. Olcaydu D, Skoda RC, Looser R, Li S, Cazzola M, Pietra D et al. The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia 2009; 23: 1924-1926.